{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:50:30Z","timestamp":1790344230809,"version":"4.1.0"},"reference-count":58,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Phosphatidylinositol (PI) species are bioactive lipids implicated in liver fibrogenesis. Hepatitis C virus (HCV) relies on host lipid metabolism for infection. The relationship between serum PI profiles, chronic HCV, and liver injury remains incompletely defined. Methods: Fourteen PI species were quantified by direct flow injection\u2013tandem mass spectrometry (FIA\u2013MS\/MS; triple quadrupole) in serum from 178 patients with chronic HCV at three time points: before treatment and at weeks 4 and 12 after starting direct-acting antiviral (DAA) therapy. Results: At baseline, PI 34:1, 36:1, and 36:3 were higher in patients with ultrasound-diagnosed cirrhosis than in those without, whereas PI 38:4, 40:5, and 40:6 were lower. In non-cirrhotic patients, PI 36:3, 36:4, 38:3, 38:4, and 38:5 increased, while PI 40:5 and 40:6 declined at weeks 4 and 12 after therapy start. In cirrhosis, viral cure was not associated with changes in PI species. By the end of therapy, cirrhotic patients showed higher PI 36:3 and lower PI 38:4 than non-cirrhotic patients. Genotype 3a was associated with lower PI 38:3, 38:4, and 38:5; the reduction in PI 38:4 persisted to the end of therapy. Across time points, most PI species did not correlate with routine markers of liver injury or inflammation. Conclusions: HCV cure remodels the serum PI profile in non-cirrhotic patients. These findings suggest that altered PI profiles are primarily linked to HCV infection, supporting a role for PI lipids in viral propagation.<\/jats:p>","DOI":"10.3390\/biomedicines13112720","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:51:43Z","timestamp":1762451503000},"page":"2720","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Hepatitis C Virus Genotype, Cirrhosis, and Viral Cure on Serum Phosphatidylinositol Species Profiles"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4216-2991","authenticated-orcid":false,"given":"Kilian","family":"Weigand","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Gastroenterology, Gemeinschaftsklinikum Mittelrhein, 56073 Koblenz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Peschel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Internal Medicine, Klinikum F\u00fcrstenfeldbruck, 82256 F\u00fcrstenfeldbruck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.20030","article-title":"Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth","volume":"39","author":"Casiraghi","year":"2004","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside","volume":"160","author":"Rockey","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/CH-211193","article-title":"Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy","volume":"79","author":"Peschel","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1111\/liv.15058","article-title":"Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease","volume":"41","author":"Broquetas","year":"2021","journal-title":"Liver Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle","volume":"22","author":"Grassi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, M. (2021). Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites, 11.","DOI":"10.3390\/metabo11050273"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3748\/wjg.v23.i13.2355","article-title":"Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b","volume":"23","author":"Endo","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e0163644","DOI":"10.1371\/journal.pone.0163644","article-title":"Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment","volume":"11","author":"Hashimoto","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Peschel, G., Grimm, J., Gulow, K., Muller, M., Buechler, C., and Weigand, K. (2020). Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110974"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1038\/s41598-021-93251-3","article-title":"Serum lipid profile in HCV patients treated with direct-acting antivirals: A systematic review and meta-analysis","volume":"11","author":"Villani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Peschel, G., Krautbauer, S., Weigand, K., Grimm, J., H\u00f6ring, M., Liebisch, G., M\u00fcller, M., and Buechler, C. (2024). Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021198"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"158471","DOI":"10.1016\/j.bbalip.2019.05.015","article-title":"Phosphatidylinositol synthesis at the endoplasmic reticulum","volume":"1865","author":"Blunsom","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bbamem.2013.10.003","article-title":"Enrichment of phosphatidylinositols with specific acyl chains","volume":"1838","author":"Epand","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1194\/jlr.M300062-JLR200","article-title":"Phosphatidylinositol promotes cholesterol transport and excretion","volume":"44","author":"Burgess","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0022-2275(20)33428-3","article-title":"Phosphatidylinositol promotes cholesterol transport in vivo","volume":"41","author":"Stamler","year":"2000","journal-title":"J. Lipid Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e0208839","DOI":"10.1371\/journal.pone.0208839","article-title":"Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007\u20132017)","volume":"13","author":"Badawi","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2016.07.045","article-title":"The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans","volume":"65","author":"Luukkonen","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21608\/jbaar.2020.135612","article-title":"The Correlation between Single Nucleotide Polymorphism of MBOAT7 and PNPLA3 Genes to the Degree of Hepatic Fibrosis in HCV Patients: An Experience from Egypt","volume":"6","author":"Youssef","year":"2020","journal-title":"J. Biosci. Appl. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102866","DOI":"10.1016\/j.ebiom.2020.102866","article-title":"MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD","volume":"57","author":"Meroni","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1038\/ncomms12757","article-title":"MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C","volume":"7","author":"Thabet","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12247","DOI":"10.1038\/s41598-018-30824-9","article-title":"Effect of MBOAT7 variant on hepatitis B and C infections in Moroccan patients","volume":"8","author":"Ezzikouri","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr. Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tiwari-Heckler, S., Gan-Schreier, H., Stremmel, W., Chamulitrat, W., and Pathil, A. (2018). Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors. Nutrients, 10.","DOI":"10.3390\/nu10050649"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"158658","DOI":"10.1016\/j.bbalip.2020.158658","article-title":"Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma","volume":"1865","author":"Buechler","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.addr.2020.06.027","article-title":"The hepatic lipidome: From basic science to clinical translation","volume":"159","author":"Pater","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jhep.2016.01.003","article-title":"Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis","volume":"64","author":"McPhail","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0009-8981(70)90395-5","article-title":"Plasma phospholipids in cirrhosis of liver and fatty liver","volume":"27","author":"Kunz","year":"1970","journal-title":"Clin. Chim. Acta"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.25653","article-title":"Review and management of drug interactions with boceprevir and telaprevir","volume":"55","author":"Kiser","year":"2012","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e16270","DOI":"10.1097\/MD.0000000000016270","article-title":"Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice","volume":"98","author":"Yen","year":"2019","journal-title":"Medicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbalip.2004.09.003","article-title":"High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm","volume":"1686","author":"Liebisch","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbalip.2008.07.008","article-title":"Mass spectrometric analysis of lipid species of human circulating blood cells","volume":"1781","author":"Leidl","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100621","DOI":"10.1016\/j.jlr.2024.100621","article-title":"The lipidomics reporting checklist a framework for transparency of lipidomic experiments and repurposing resource data","volume":"65","author":"Kopczynski","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C","volume":"214","author":"Hengst","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e0179400","DOI":"10.1371\/journal.pone.0179400","article-title":"Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon","volume":"12","author":"Mascia","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3851\/IMP3094","article-title":"Effect of antiviral therapy for HCV on lipid levels","volume":"21","author":"Mauss","year":"2017","journal-title":"Antivir. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/5584_2020_604","article-title":"Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review","volume":"1323","author":"Sagnelli","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Weigand, K., Peschel, G., Grimm, J., Horing, M., Krautbauer, S., Liebisch, G., Muller, M., and Buechler, C. (2024). Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158161"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/1319-2442.106235","article-title":"Ultrasound predictors of compensated liver cirrhosis in hemodialysis patients with hepatitis C","volume":"24","author":"Dzikova","year":"2013","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00261-017-1211-7","article-title":"Evaluation of hepatic fibrosis: A review from the society of abdominal radiology disease focus panel","volume":"42","author":"Horowitz","year":"2017","journal-title":"Abdom. Radiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbadis.2018.01.009","article-title":"Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?","volume":"1864","author":"Lambrecht","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index","volume":"37","author":"Bachofner","year":"2017","journal-title":"Liver Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0004-28032015000300011","article-title":"Lipid profile of cirrhotic patients and its association with prognostic scores: A cross-sectional study","volume":"52","author":"Bassani","year":"2015","journal-title":"Arq. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1042\/BST20190205","article-title":"How is the acyl chain composition of phosphoinositides created and does it matter?","volume":"47","author":"Barneda","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1091\/mbc.e16-09-0668","article-title":"The acyltransferase LYCAT controls specific phosphoinositides and related membrane traffic","volume":"28","author":"Bone","year":"2017","journal-title":"Mol. Biol. Cell."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Todorovic, N., Filipovic, A., Simic, J., Markovic, M., Stevanovic, O., Malinic, J., Katanic, N., Mitrovic, N., and Nikolic, N. (2023). HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216048"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0168-8278(05)80330-7","article-title":"Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease","volume":"21","author":"Mita","year":"1994","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1510939","DOI":"10.3389\/fcimb.2025.1510939","article-title":"Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy","volume":"15","author":"Ran","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105348","DOI":"10.1016\/j.chemphyslip.2023.105348","article-title":"Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia","volume":"257","author":"Cerda","year":"2023","journal-title":"Chem. Phys. Lipids"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.34172\/hpp.025.42914","article-title":"Serum phospholipids during aging: A comprehensive systematic review of cross-sectional and case-control studies","volume":"15","author":"Zarezadeh","year":"2025","journal-title":"Health Promot. Perspect"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/lipd.12293","article-title":"Lipidomic Analysis of Plasma from Healthy Men and Women Shows Phospholipid Class and Molecular Species Differences between Sexes","volume":"56","author":"West","year":"2021","journal-title":"Lipids"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2720\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:17:20Z","timestamp":1762453040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/11\/2720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["biomedicines13112720"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13112720","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}